Barclays lowered the firm’s price target on Haleon (HLN) to 450 GBp from 475 GBp and keeps an Overweight rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLN:
- Haleon breaks ground on new GBP 130M global oral health center
- Haleon Completes Acquisition of Remaining Stake in China JV
- Haleon Completes First Tranche of Share Buyback Program
- Haleon PLC Executes Share Buyback to Enhance Shareholder Value
- Haleon names Carl Haney as Chief Research & Development Officer